Podcast: Finnegan wins two honours at the LMG Life Sciences Awards
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: Finnegan wins two honours at the LMG Life Sciences Awards

Finnegan's Naoki Yoshida (left) and John Livingstone (right)

Chris Adams speaks to the IP firm about its success, firm strategy and the changing legal landscape during the global pandemic




Finnegan worked closely with Kaken Pharmaceutical and Bausch Health on the recent Kaken v Iancu case, for which the firm received Patent Impact Case of the Year at the 2020 LMG Life Sciences Awards. Finnegan was also recognised as Patent Strategy Firm of the Year. 

In this podcast, lead researcher Chris Adams chats to the team about how the case highlights the firm's efforts to align itself with client goals to achieve results. 

The discussion covers life sciences in the age of coronavirus through cutting-edge innovations, vaccines and tech. Finnegan talks about training and developing its IP attorneys, and how an IP-driven portfolio must be aligned with business perspectives.

Joining Chris is Rob Gorman, senior vice president and assistant general counsel for Bausch Health, Naoki Yoshida, managing partner of Finnegan’s Tokyo office, and John Livingstone, managing partner of the firm’s Atlanta office.

To find out more about the LMG Life Sciences Awards and the 2020 winners, please visit www.lmglifesciencesawards.com/winners-americas-2020



more from across site and ros bottom lb

More from across our site

Firms explain how monitoring, referrals and relationships with foreign firms helped them get more work at the TTAB
Luke Toft explains why he moved back to Fox Rothschild after working in-house at Sleep Number for five months
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
In a seminal ruling, the Beijing Internet Court said images generated by Stable Diffusion counted as original works
Boston-based John Lanza is hoping to work more with life sciences colleagues on the ‘exciting’ application of AI to drug discovery
The Delhi High Court has expressed its willingness to set global licensing terms in the Nokia-Oppo dispute, but it must deal with longstanding problems first
Some patent counsel are still encountering errors even though the USPTO has fully transitioned to the new system
A senior USPTO attorney spoke at a Nokia-sponsored event on the EU’s proposed SEP Regulation today, November 29
IP counsel are ‘flooded’ with queries from clients worried about deepfakes, but the law has so far come up short
Each week Managing IP speaks to a different IP practitioner about their life and career